> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-10/
- Published: 2020-02-02T12:00:00.000Z
- Updated: 2026-09-14T16:01:15.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5145998

[**Guide on Retroviral Vector-Based Gene Therapies**](https://www.fdaweb.com/guide-on-retroviral-vector-based-gene-therapies/)  
*Federal Register* notice: FDA makes available a final guidance on testing retroviral vector-based human gene therapy products. 01/31/2020  

[**Guide on Gene Therapy Observational Studies**](https://www.fdaweb.com/guide-on-gene-therapy-observational-studies/)  
*Federal Register* notice: FDA makes available a final guidance entitled “Long Term Follow-Up After Administration of Human Gene Therapy Products.” 01/31/2020  

[**Guide on Creutzfeldt-Jakob Disease Risk Reductions**](https://www.fdaweb.com/guide-on-creutzfeldt-jakob-disease-risk-reductions/)  
*Federal Register* notice: FDA makes available a draft guidance on recommendations to reduce the possible risk of transmission of Creutzfeldt-Jakob Disease. 01/31/2020  

[**Guide on CMC Info for Gene Therapies**](https://www.fdaweb.com/guide-on-cmc-info-for-gene-therapies/)  
*Federal Register* notice: FDA released a final guidance on Chemistry, Manufacturing, and Control information for gene therapy INDs. 01/30/2020  

[**Hemophilia Gene Therapy Development Guide**](https://www.fdaweb.com/hemophilia-gene-therapy-development-guide/)  
*Federal Register* notice: FDA posts a final guidance on human gene therapy development for hemophilia. 01/30/2020  

[**Draft Guide on Gene Therapy Sameness**](https://www.fdaweb.com/draft-guide-on-gene-therapy-sameness/)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Interpreting Sameness of Gene Therapy Products Under the Orphan Drug Regulations.” 01/30/2020  

[**Guide on Retinal Disorder Gene Therapy Development**](https://www.fdaweb.com/guide-on-retinal-disorder-gene-therapy-development/)  
*Federal Register* notice: FDA posts a final guidance on human gene therapy for retinal disorders. 01/30/2020

[**Final Guide on Rare Disease Gene Therapies**](https://www.fdaweb.com/final-guide-on-rare-disease-gene-therapies/)  
*Federal Register* notice: FDA makes available a final guidance on rare disease gene therapy development. 01/30/2020  

[**Voting Members Needed for CDRH Patient Panel**](https://www.fdaweb.com/voting-members-needed-for-cdrh-patient-panel/)  
*Federal Register* notice: FDA requests nominations for voting members to serve on CDRHֺֺ’s Patient Engagement Advisory Committee. 01/29/2020  

[**16 Information Collections Cleared by OMB**](https://www.fdaweb.com/16-information-collections-cleared-by-omb/)  
*Federal Register* notice: FDA posts a list of 16 information collections approved by OMB. 01/29/2020  

[**DTC Study on Ad Endorser Influence**](https://www.fdaweb.com/dtc-study-on-ad-endorser-influence/)  
*Federal Register* notice: FDA seeks comments on a proposed study entitled “Endorser Status and Explicitness of Payment in Direct-to-Consumer Promotion.” 01/28/2020  

[**Guide on Arthroscopy Pump Tubing Sets**](https://www.fdaweb.com/guide-on-arthroscopy-pump-tubing-sets/)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Arthroscopy Pump Tubing Sets Intended for Multiple Patient Use — Premarket Notification (510(k)) Submissions.” 01/28/2020